171 related articles for article (PubMed ID: 20417190)
1. PARP inhibitors: new tools to protect from inflammation.
Giansanti V; Donà F; Tillhon M; Scovassi AI
Biochem Pharmacol; 2010 Dec; 80(12):1869-77. PubMed ID: 20417190
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribose) polymerase-1 (PARP-1) and its therapeutic implications.
Sodhi RK; Singh N; Jaggi AS
Vascul Pharmacol; 2010; 53(3-4):77-87. PubMed ID: 20633699
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the enzymatic catalysis of poly(ADP-ribose) polymerase by dsDNA, polyamines, Mg2+, Ca2+, histones H1 and H3, and ATP.
Kun E; Kirsten E; Mendeleyev J; Ordahl CP
Biochemistry; 2004 Jan; 43(1):210-6. PubMed ID: 14705947
[TBL] [Abstract][Full Text] [Related]
4. Poly ADP-ribose polymerase-1 and health.
Kirkland JB
Exp Biol Med (Maywood); 2010 May; 235(5):561-8. PubMed ID: 20463295
[TBL] [Abstract][Full Text] [Related]
5. Altered poly(ADP-ribose) metabolism impairs cellular responses to genotoxic stress in a hypomorphic mutant of poly(ADP-ribose) glycohydrolase.
Gao H; Coyle DL; Meyer-Ficca ML; Meyer RG; Jacobson EL; Wang ZQ; Jacobson MK
Exp Cell Res; 2007 Mar; 313(5):984-96. PubMed ID: 17276427
[TBL] [Abstract][Full Text] [Related]
6. Poly(ADP-ribose) polymerase as a drug target for cardiovascular disease and cancer: an update.
Horvath EM; Szabó C
Drug News Perspect; 2007 Apr; 20(3):171-81. PubMed ID: 17520094
[TBL] [Abstract][Full Text] [Related]
7. Cytoprotective effect of gallotannin in oxidatively stressed HaCaT keratinocytes: the role of poly(ADP-ribose) metabolism.
Bakondi E; Bai P; Erdélyi K; Szabó C; Gergely P; Virág L
Exp Dermatol; 2004 Mar; 13(3):170-8. PubMed ID: 14987257
[TBL] [Abstract][Full Text] [Related]
8. Poly(ADP-ribose) and carcinogenesis.
Masutani M; Nakagama H; Sugimura T
Genes Chromosomes Cancer; 2003 Dec; 38(4):339-48. PubMed ID: 14566854
[TBL] [Abstract][Full Text] [Related]
9. [Neuronal death: potential role of the nuclear enzyme, poly (ADP-ribose) polymerase].
Boulu RG; Mesenge C; Charriaut-Marlangue C; Verrecchia C; Plotkine M
Bull Acad Natl Med; 2001; 185(3):555-63; discussion 564-5. PubMed ID: 11501263
[TBL] [Abstract][Full Text] [Related]
10. An enzymatic assay for poly(ADP-ribose) polymerase-1 (PARP-1) via the chemical quantitation of NAD(+): application to the high-throughput screening of small molecules as potential inhibitors.
Putt KS; Hergenrother PJ
Anal Biochem; 2004 Mar; 326(1):78-86. PubMed ID: 14769338
[TBL] [Abstract][Full Text] [Related]
11. [Poly(ADP-ribose) polymerase-1 as a regulator of protein-nucleic acid interactions in the processes responding to genotoxic action].
Sukhanova MV; Lavrik OI; Khodyreva SN
Mol Biol (Mosk); 2004; 38(5):834-47. PubMed ID: 15554186
[TBL] [Abstract][Full Text] [Related]
12. Bcl-2 prevents topoisomerase II inhibitor GL331-induced apoptosis is mediated by down-regulation of poly(ADP-ribose)polymerase activity.
Kuo ML; Shen SC; Yang CH; Chuang SE; Cheng AL; Huang TS
Oncogene; 1998 Oct; 17(17):2225-34. PubMed ID: 9811453
[TBL] [Abstract][Full Text] [Related]
13. Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects.
Pogrebniak A; Schemainda I; Pelka-Fleischer R; Nüssler V; Hasmann M
Eur J Med Res; 2003 Oct; 8(10):438-50. PubMed ID: 14594650
[TBL] [Abstract][Full Text] [Related]
14. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors.
Jagtap P; Szabó C
Nat Rev Drug Discov; 2005 May; 4(5):421-40. PubMed ID: 15864271
[TBL] [Abstract][Full Text] [Related]
15. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.
Endres M; Wang ZQ; Namura S; Waeber C; Moskowitz MA
J Cereb Blood Flow Metab; 1997 Nov; 17(11):1143-51. PubMed ID: 9390645
[TBL] [Abstract][Full Text] [Related]
16. Differential contribution of poly(ADP-ribose)polymerase-1 and -2 (PARP-1 and -2) to the poly(ADP-ribosyl)ation reaction in rat primary spermatocytes.
Tramontano F; Malanga M; Quesada P
Mol Hum Reprod; 2007 Nov; 13(11):821-8. PubMed ID: 17766683
[TBL] [Abstract][Full Text] [Related]
17. Chain length analysis of ADP-ribose polymers generated by poly(ADP-ribose) polymerase (PARP) as a function of beta-NAD+ and enzyme concentrations.
Mendoza-Alvarez H; Chavez-Bueno S; Alvarez-Gonzalez R
IUBMB Life; 2000 Aug; 50(2):145-9. PubMed ID: 11185961
[TBL] [Abstract][Full Text] [Related]
18. Gender differences in the endotoxin-induced inflammatory and vascular responses: potential role of poly(ADP-ribose) polymerase activation.
Mabley JG; Horváth EM; Murthy KG; Zsengellér Z; Vaslin A; Benko R; Kollai M; Szabó C
J Pharmacol Exp Ther; 2005 Nov; 315(2):812-20. PubMed ID: 16079296
[TBL] [Abstract][Full Text] [Related]
19. Importance of poly(ADP-ribose) glycohydrolase in the control of poly(ADP-ribose) metabolism.
Davidovic L; Vodenicharov M; Affar EB; Poirier GG
Exp Cell Res; 2001 Aug; 268(1):7-13. PubMed ID: 11461113
[TBL] [Abstract][Full Text] [Related]
20. Relation between carcinogenesis, chromatin structure and poly(ADP-ribosylation) (review).
Boulikas T
Anticancer Res; 1991; 11(2):489-527. PubMed ID: 1905900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
